Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

226 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ilixadencel, a Cell-based Immune Primer, plus Sunitinib Versus Sunitinib Alone in Metastatic Renal Cell Carcinoma: A Randomized Phase 2 Study.
Lindskog M, Laurell A, Kjellman A, Melichar B, Rey PM, Zieliński H, Villacampa F, Bigot P, Zoltan B, Parikh O, Alba DV, Jellvert Å, Flaskó T, Gallardo E, Caparrós MJR, Purkalne G, Suenaert P, Karlsson-Parra A, Ljungberg B. Lindskog M, et al. Among authors: bigot p. Eur Urol Open Sci. 2022 Apr 26;40:38-45. doi: 10.1016/j.euros.2022.03.012. eCollection 2022 Jun. Eur Urol Open Sci. 2022. PMID: 35638086 Free PMC article.
External Validation of the ASSURE Model for Predicting Oncological Outcomes After Resection of High-risk Renal Cell Carcinoma (RESCUE Study: UroCCR 88).
Khene ZE, Larcher A, Bernhard JC, Doumerc N, Ouzaid I, Capitanio U, Nouhaud FX, Boissier R, Rioux-Leclercq N, De La Taille A, Barthelemy P, Montorsi F, Rouprêt M, Bigot P, Bensalah K; French Committee of Urologic Oncology. Khene ZE, et al. Among authors: bigot p. Eur Urol Open Sci. 2021 Oct 5;33:89-93. doi: 10.1016/j.euros.2021.09.004. eCollection 2021 Nov. Eur Urol Open Sci. 2021. PMID: 34661173 Free PMC article.
The Impact of Histological Variants on Oncological Outcomes After Surgical Resection of a Nonmetastatic Renal Cell Carcinoma with Tumor Thrombus: A Multi-institutional Study.
Fleury R, Bertail T, Bensalah K, Bernhard JC, Audenet F, Waeckel T, Parier B, Champy C, Olivier J, Doumerc N, Tricard T, Branger N, Bruyere F, Neuville P, Surlemont L, Alexandre Long J, Fontenil A, Vallee M, Roupret M, Boissier R, Jacques Patard J, Durand M, Ouzaid I, Rouget B, Durand X, Joncour C, Belas O, Denise Gomez F, Bigot P, Khene ZE; members of the French Committee of Urologic Oncology CCAFU. Fleury R, et al. Among authors: bigot p. Eur Urol Open Sci. 2024 Mar 8;62:123-130. doi: 10.1016/j.euros.2024.02.015. eCollection 2024 Apr. Eur Urol Open Sci. 2024. PMID: 38496822 Free PMC article.
Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population.
Neuzillet Y, Tillou X, Mathieu R, Long JA, Gigante M, Paparel P, Poissonnier L, Baumert H, Escudier B, Lang H, Rioux-Leclercq N, Bigot P, Bernhard JC, Albiges L, Bastien L, Petit J, Saint F, Bruyere F, Boutin JM, Brichart N, Karam G, Branchereau J, Ferriere JM, Wallerand H, Barbet S, Elkentaoui H, Hubert J, Feuillu B, Theveniaud PE, Villers A, Zini L, Descazeaux A, Roupret M, Barrou B, Fehri K, Lebret T, Tostain J, Terrier JE, Terrier N, Martin L, Dugardin F, Galliot I, Staerman F, Azemar MD, Irani J, Tisserand B, Timsit MO, Sallusto F, Rischmann P, Guy L, Valeri A, Deruelle C, Azzouzi AR, Chautard D, Mejean A, Salomon L, Rigaud J, Pfister C, Soulié M, Kleinclauss F, Badet L, Patard JJ; Comité de Transplantation de l'Association Française d'Urologie; Comité de Cancérologie de l'Association Française d'Urologie. Neuzillet Y, et al. Among authors: bigot p. Eur Urol. 2011 Aug;60(2):366-73. doi: 10.1016/j.eururo.2011.02.035. Epub 2011 Mar 2. Eur Urol. 2011. PMID: 21377780
Nephrectomy After Complete Response to Immune Checkpoint Inhibitors for Metastatic Renal Cell Carcinoma: A New Surgical Challenge?
Pignot G, Thiery-Vuillemin A, Walz J, Lang H, Bigot P, Werle P, Balssa L, Geoffrois L, Leblanc L, Albigès L, di Nunno V, Bensalah K, Ladoire S, Gravis G, Barthélémy P. Pignot G, et al. Among authors: bigot p. Eur Urol. 2020 Jun;77(6):761-763. doi: 10.1016/j.eururo.2019.12.018. Epub 2020 Jan 3. Eur Urol. 2020. PMID: 31911011 No abstract available.
Percutaneous Ablation Versus Surgical Resection for Local Recurrence Following Partial Nephrectomy for Renal Cell Cancer: A Propensity Score Analysis (REPART Study-UroCCR 71).
Brassier M, Khene ZE, Bernhard JC, Dang VT, Ouzaid I, Nouhaud FX, Olivier J, Nedelcu C, Grenier N, Beuzit L, Doumerc N, Bensalah K, Bigot P; Members of the French Committee of Urologic Oncology. Brassier M, et al. Among authors: bigot p. Eur Urol Focus. 2022 Jan;8(1):210-216. doi: 10.1016/j.euf.2021.02.007. Epub 2021 Feb 20. Eur Urol Focus. 2022. PMID: 33622625
226 results